UK markets closed

Extendicare Inc. (0S9E.L)

LSE - LSE Delayed price. Currency in CAD
Add to watchlist
7.23+0.08 (+1.12%)
At close: 04:14PM BST
Full screen
Loading interactive chart…
  • GlobeNewswire

    Extendicare Announces April 2024 Dividend of C$0.04 per Share

    MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a lead

  • GlobeNewswire

    Extendicare Announces Timing of 2024 First Quarter Results and Conference Call

    MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2024 after market close on Wednesday, May 15, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Thursday, May 16, 2024, at 11:30 a.m. (ET) to discuss the results. To partici

  • GlobeNewswire

    Extendicare Announces 2023 Fourth Quarter and Year End Results

    MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023. Results are presented in Canadian dollars unless otherwise noted. Fourth Quarter 2023 Highlights Adjusted EBITDA(1) increased $19.5 million in Q4 to $28.7 million, driven by home health care volume growth and rate increases; growth in managed services, including full quarter impact of the Revera and Axium